MRK stock: buy or sell
Updated on:
Apr 22nd, 2021
2
MRK stock brief
- Counting on Wednesday, it's been 5 consecutive sessions in positive for Merck. Price closed on Wednesday at $79.23 after just changing a 0.84%.
- Merck is presenting its earnings report next Tuesday
- The price is currently above the upper Bollinger band, which often indicates a near-term correction
- On Tuesday broke out above its latest top at $78.55
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health segments.
Should I buy Merck stock?
Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best
Is $MRK stock a buy?
Currently, Merck stock doesn't match any of these trading strategies, so our recommendation is not to buy now. This doesn't mean $MRK will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems
Should I sell Merck stock?
"To sell or not to sell", if you are holding Merck stock?. As when we have to buy shares, deciding when is appropiate time to sell is not a haphazard decision, and we must follow our own trading strategy. When selling, as well as buying, our strategies are very simple to use and are only valid for selling stocks you already own, not for shorting Merck stock
As a rule of thumb, you must never mantain a trade that leads to greater losses than those expected by the time of purchase. The timing to sell shares must always be determined by the stop-loss (automatic or manual)
Is it time to sell Merck stock?
In the current situation of Merck there is not any eligible sell setup, so Merck stock holders with operations in profit can keep their positions
Merck ratings
In the previous 30 days we couldn't find any rating for Merck
Merck stock analysis
SMAs overview
Supports and resistances
The current resistance levels are:
The current support levels are:
Bollinger bands
The distance between the upper and lower bands is 4.08%, thus meaning that price volatility is low. The compression of the Bollinger bands is usually a sign of a sharp price movement (up or down), so we must be watchful and manage our buy or sell orders correctly
Relative strength index
The RSI broke out the oversold line of 30 in early March after just being in the oversold zone for a single day (what can be considered a strength sign). The RSI reading on Wednesday was 68.41. Merck shares exploded a 10.43% since RSI left the oversold zone
Merck stock price history
Merck started trading priced at an adjusted price1 of $0.35 on Jan 1970. Since then, MRK stock has risen by 22,537.14%, with an average of 441.90% per year. An investment of $1,000USD on the IPO would be valued $226,371.43 today.
1: Adjusted price after possible price splits or reverse-splits
Price target for Merck stock
How much a stock will be priced tomorrow or next week is quite unpredictable. Banks and financial organisations issue their analysis forecasting how a stock will performance in the future.
Along with buy or sell recommendations, brokerage institutions publish their price forecasts based on the stock price action and the company fundamental data. Most of these forecasts follow the release of new financial data by the company, and many times. Again, these predictions are not direct recommendations for small traders and should not be followed blindly.
We don't have any target price posted in the previous month for Merck.
Earnings and financials
MRK ($MRK) will host the earnings call next Tuesday. Market forecasts of $1.63, compared to Q4 that was $1.32.
Earnings call was hosted by Merck ($MRK) last February after presenting the earnings report. MRK reported earnings of $1.32 per share on revenue of $12.5 billion. The analysts estimate was $1.38 per share on revenue of $12.7 billion.
This compares to Earnings of $1.16 per share a year ago, so reported EPS means an increase of 13.79%. Sales inched a 5.45% on an annualized basis in the , from $118.7B to $125.2B last quarter.Merck performance
| Company | 1m | 3m | 6m |
|---|---|---|---|
| Merck ($MRK) | 2.80% | -2.30% | 2.00% |
Important note:
The opinions contained in this post are personal and not recommendations for you to buy or sell shares. The author of this article does not know the individual conditions of the reader, his or her own financial statements or his or her own best interests at any given time. All users should speak with their financial advisor before buying or selling any securities Opinions are posted for educative reasons onlyMRK summary
| Wednesday, April 21st, 2021 | |
|---|---|
| Open | $78.93 |
| Close | $79.23 |
| Day range | $78.67 - $79.49 |
| Previous close | $78.57 |
| Session gain | 0.84% |
| Average true range | $1.14 |
| 50d mov avg | $75.32 |
| 100d mov avg | $77.58 |
| 200d mov avg | $78.60 |
| Earnings date | April 27th, 2021 |